BioNTech Says Making More Covid-19 Doses Depends on Many Factors

About This Source - Bloomberg Markets and Finance

Bloomberg Markets and Finance features news about financial markets from around the world. Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Bloomberg Books #Ad

Recent from Bloomberg Markets and Finance:

  • HSBC Economist Henry Sees ‘Increasingly Uneven’ Global Recovery
  • Fauci ‘Concerned’ About Delaying Second Covid Vaccine Dose
  • Covid Vaccine Shortage May Last Months: Johns Hopkins
  • Bloomberg Markets and Finance published this video item, entitled “BioNTech Says Making More Covid-19 Doses Depends on Many Factors” – below is their description.

    Dec.22 — BioNTech SE Chief Commercial Officer Sean Marett says the ability to make more than 1.3 billion Covid-19 vaccine doses with its partner Pfizer Inc. depends on many factors. He speaks on “Bloomberg Surveillance.”

    Bloomberg Markets and Finance YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Coronavirus: One year since Canada’s 1st COVID-19 case
  • How CBC News is tracking vaccine rollout
  • Vaccine inequality may have an economic impact, says report
  • Kremlin Downplays Navalny Protests; Mexico’s President Tests Positive: World Brief
  • Biden to impose new travel bans as alarm of new COVID-19 variants grow
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Australia approves Pfizer COVID-19 vaccine
  • Pfizer vaccine approved for use in Australia | 9 News Australia
  • Pfizer COVID-19 vaccine approved for use in Australia ahead of rollout | ABC News
  • Pfizer vaccine given the green light in Australia | 7NEWS
  • Victorians should start to receive Covid-19 jabs in a month | 7NEWS
  • Leave a Comment